Clover Health's stock could be delisted from the Nasdaq, the company disclosed. Clover told investors in a filing last week with the Securities and Exchange Commission that it was notified by the ...

The Clover Health president links the company’s open-network model to greater equity for patients and providers. Health equity and open-network strategy are two of Andrew Toy’s favorite subjects. The ...

WILMINGTON, Del., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive Officer, ...

Clover Health Investments, a health insurance company, is facing significant challenges. The company's unique pitch focused on leveraging technology and data analytics to provide healthcare to ...

Clover Health will be getting a new CEO in the new year. The insurtech company announced Monday that founder and current Chief Vivek Garipalli will transition out of the CEO position on Jan. 1 but ...

Clover Health Investments, Corp. announced that its Chief Financial Officer, Peter Kuipers, will present at the Canaccord Genuity 45th Annual Growth Conference on August 12, 2025, at 11:00 a.m. ET, ...

We recently compiled a list of the 15 Small-Cap Stocks Poised to Outperform in 2025. In this article, we are going to take a look at where Clover Health Investments Corp. (NASDAQ:CLOV) stands against ...

Clover Health (NASDAQ:CLOV) is a Medicare Advantage insurer in the U.S. that has crashed more than 74% in 2021. CLOV stock was trading near $15 per share in early January, crashed until May, then ...

WILMINGTON, Del. - Counterpart Health, Inc., a subsidiary of Clover Health Investments, Corp. (NASDAQ:CLOV), which has seen ...

Using technology to cut healthcare costs and improve service has helped Clover Health grow revenue quickly. A recent huge surge in both capital investments and stock-based compensation has plunged the ...

Health insurance company Clover Health (NASDAQ:CLOV) announced better-than-expected revenue in Q3 CY2025, with sales up 50.1% year on year to $496.7 million. Its GAAP loss of $0.05 per share was $0.02 ...

Chamath Palihapitiya helped take Clover Health public through a SPAC reverse merger. When “SPAC King” Chamath Palihapitiya announced his special purpose acquisition company IPOC was merging with ...